The Clinical Numbers at 12 Weeks

Data from the STEP clinical trials (the large-scale studies that led to Wegovy's approval) provides the most reliable benchmarks for semaglutide weight loss over time.

At 12 weeks (approximately 3 months), the average results on semaglutide 2.4mg (the target maintenance dose for Wegovy) were:

• Average weight loss: 5-7% of starting body weight
• For a 250-lb person: approximately 12-18 lbs lost
• For a 200-lb person: approximately 10-14 lbs lost
• For a 300-lb person: approximately 15-21 lbs lost

These are averages. Some people lose more, some lose less. The distribution looks like a bell curve: a small percentage of "super responders" lose 10%+ at 12 weeks, while a small percentage respond minimally (under 3%). Most people fall somewhere in that 5-7% range.

It's also important to note that at 3 months, most people are still titrating up through the dose escalation schedule. They haven't been on the full 2.4mg dose for long, if at all. The most significant weight loss acceleration typically happens between months 3 and 9.

The Dose Progression Timeline

Understanding where you are in the dose progression helps explain why the first 3 months show moderate results compared to what comes later. Here's the standard Wegovy titration schedule:

At the 3-month mark, you've likely just reached the 1.0mg dose. That means you've spent two-thirds of your time on sub-therapeutic doses that were designed for tolerability, not maximum weight loss. This is by design. The slow titration minimizes nausea and GI side effects.

Some providers adjust this timeline based on individual response. If you're tolerating the medication well, they may accelerate the increases. If side effects are significant, they may hold at a lower dose longer. Both approaches are valid.

For compounded semaglutide users, dose schedules vary by provider. Some start at higher doses, some titrate differently. The specific milligram amount matters less than the trend: are you losing weight? Is the trajectory heading in the right direction?

What Affects Your Results at 3 Months

If you're above the average, great. If you're below it, don't panic. Several factors influence individual results:

Starting Weight and BMI

People with higher starting weights tend to lose more total pounds but may lose a similar percentage. A person starting at 300 lbs losing 6% has lost 18 lbs. A person starting at 180 lbs losing 6% has lost about 11 lbs. Both are on track, but the raw numbers look different.

Metabolic Health

People with insulin resistance, type 2 diabetes, or PCOS often lose weight more slowly in the first few months. Semaglutide addresses insulin resistance over time, but the metabolic improvements may need to compound before weight loss accelerates. Patience is especially important for this group.

Diet Quality

Semaglutide suppresses appetite, but it doesn't choose your food. Someone eating 1,200 calories of lean protein and vegetables will lose faster than someone eating 1,200 calories of processed carbs and sugar. Protein intake is particularly important: higher protein means more muscle preservation and a more favorable body composition change.

Exercise

Adding exercise, especially resistance training, may actually slow the number on the scale while improving body composition. If you started lifting weights in month 2 and the scale stalled, you may be gaining muscle while losing fat. The mirror, clothing fit, and measurements tell a more complete story than the scale alone.

Sleep

Poor sleep raises cortisol, increases insulin resistance, and can slow weight loss by 30-55% according to research on caloric restriction. If you're sleeping less than 6 hours per night, it's directly impacting your results.

Stress

Chronic stress elevates cortisol, which promotes fat storage, particularly visceral abdominal fat. Cortisol also increases water retention, which can mask fat loss on the scale. Managing stress through walking, meditation, or other practices supports better results.

Medications

Some medications promote weight gain or make weight loss harder. Common examples include certain antidepressants (SSRIs, mirtazapine), beta-blockers, insulin, corticosteroids, and some antihistamines. If you're on any of these, discuss with your prescriber whether alternatives exist.

Menstrual Cycle

Women may see 2-5 lbs of water weight fluctuation throughout their cycle. If your 3-month weigh-in happens during the luteal phase (the week before your period), the scale may show a higher number that doesn't reflect actual fat loss. Track your weight across entire cycles, not single data points.

The Side Effect Timeline at 3 Months

By month 3, most people have a clear picture of how semaglutide affects them. Here's the typical side effect trajectory:

Nausea

Usually worst during weeks 1-4 and after each dose increase. By month 3, most people have either adapted or learned which foods and behaviors minimize it. If you're still experiencing significant nausea at 12 weeks on a stable dose, talk to your provider. Persistent nausea isn't something you should just push through indefinitely.

Constipation

Develops in the first month for many users and can persist. Slowed gastric emptying combined with reduced food and water intake creates a perfect storm for constipation. By month 3, you should have a management strategy in place: adequate fiber, plenty of water, walking, and possibly a mild laxative or stool softener as recommended by your provider.

Fatigue

Common in the first 4-6 weeks as your body adjusts to significantly fewer calories. Most people report improved energy by month 3 as their body adapts to the new caloric intake. If fatigue persists or worsens at month 3, check with your provider. Low protein intake, dehydration, or micronutrient deficiencies may be contributing.

Appetite Changes

By month 3, the appetite suppression effect is well-established for most people. You may notice that food has become less interesting, portions feel naturally smaller, and the urgency around meals has diminished. This is the medication working as intended.

Hair Thinning

Some users notice increased hair shedding starting around months 2-4. This is called telogen effluvium and is related to rapid weight loss and caloric restriction, not the medication specifically. Adequate protein intake (1g per pound of ideal body weight) and ensuring sufficient vitamins (iron, zinc, biotin) can help minimize it. The shedding is typically temporary.

Injection Site Reactions

Redness, itching, or a small bump at the injection site. Usually mild and resolves within a few days. Rotating injection sites helps. By month 3, you've done 12+ injections and likely have a preferred spot and technique.

When to Worry About Slow Progress

Not everyone loses weight at the same rate. But there are signs that something may need adjustment:

Red Flags

• Zero weight loss after 12 weeks. Some people are non-responders to semaglutide. If the scale hasn't moved at all after 3 months of consistent use, your provider may recommend switching to tirzepatide or evaluating other factors.
• Less than 2% body weight lost at 12 weeks. While individual variation exists, losing less than 2% in 3 months suggests the current approach may need modification.
• Weight loss stopped after an initial drop. Losing 5 lbs in month 1 and nothing in months 2-3 could indicate a plateau, but it could also indicate inadequate dose titration, dietary issues, or counteracting medications.

Things That Are Normal (Even If Frustrating)

• Weeks where the scale doesn't move. Weight loss is never linear. Water retention, hormonal fluctuations, and normal biological variation create plateaus that resolve on their own.
• Losing faster in month 1 and slowing down. The initial rapid loss often includes water weight. Subsequent months are more likely pure fat loss, which is slower but more meaningful.
• A 2-3 lb fluctuation day to day. This is water, not fat. Weigh yourself weekly under consistent conditions (same time, same clothing) and track the trend, not individual readings.
• Losing inches but not pounds. If you're exercising, especially lifting weights, body recomposition can keep the scale stable while your body changes shape. Take measurements and photos monthly.

What Comes Next: Months 4-6

If the first 3 months are the warmup, months 4-6 are where semaglutide really hits its stride. Most people reach the full 2.4mg dose during month 5, and the weight loss curve steepens. Average results at 6 months are typically 10-12% of starting body weight.

Here's what to focus on going forward:

• Continue titrating up as prescribed. Don't stay on a lower dose out of fear of side effects if your weight loss has stalled. The higher doses are where the most benefit occurs.
• Double down on protein. As weight loss accelerates, muscle preservation becomes even more important. Keep aiming for 1g of protein per pound of ideal body weight.
• Start or continue resistance training. If you haven't started lifting, month 4 is a great time. You'll have more experience with the medication, your diet will be more dialed in, and your energy should be more stable.
• Get bloodwork. A 3-month check-in with your provider should include metabolic labs: fasting glucose, HbA1c, lipid panel, thyroid function. These numbers often improve significantly alongside the weight loss.
• Celebrate the progress. 5-7% body weight lost in 3 months is clinically meaningful. It improves blood pressure, blood sugar, inflammation markers, and joint health. Even if it doesn't feel dramatic, your body is already healthier.

The Bottom Line

Three months on semaglutide is still early. You've spent most of that time on starter doses designed for tolerability, not maximum effect. Average weight loss of 5-7% of body weight at 12 weeks is right on track. If you're above that, excellent. If you're below it, evaluate the factors that influence results (diet, sleep, stress, dose) and give it time. The steepest part of the weight loss curve is still ahead of you. Stay consistent, keep your protein high, and let the medication do its work.